Document is current
Any future updates will be listed below
-
Authors
Feto, Naser Aliye
Asuzu, Peace
Wan, Jim
Stentz, Frankie
Dagogo-Jack, Sam
Mandal, Nawajes
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK128129)
National Institute of Diabetes and Digestive and Kidney Diseases (DK067269)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 48411)
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 16 April 2025
First Online: 5 May 2025
Declarations
:
: The authors report no conflicts of interest regarding the content of the manuscript.
: The CASPID study was approved by the Institutional Review Board (IRB) of the University of Tennessee Health Science Center (UTHSC) (IRB Approval #21–07936-FB) and conducted at the UTHSC General Clinical Research Center (GCRC). All participants gave written informed consent before taking part in the study.
